ID DAPB_BIFLO Reviewed; 251 AA. AC Q8G526; DT 15-DEC-2003, integrated into UniProtKB/Swiss-Prot. DT 01-MAR-2003, sequence version 1. DT 16-JUN-2009, entry version 39. DE RecName: Full=Dihydrodipicolinate reductase; DE Short=DHPR; DE EC=1.3.1.26; GN Name=dapB; OrderedLocusNames=BL1194; OS Bifidobacterium longum. OC Bacteria; Actinobacteria; Actinobacteridae; Bifidobacteriales; OC Bifidobacteriaceae; Bifidobacterium. OX NCBI_TaxID=216816; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=NCC 2705; RX MEDLINE=22294977; PubMed=12381787; DOI=10.1073/pnas.212527599; RA Schell M.A., Karmirantzou M., Snel B., Vilanova D., Berger B., RA Pessi G., Zwahlen M.-C., Desiere F., Bork P., Delley M., RA Pridmore R.D., Arigoni F.; RT "The genome sequence of Bifidobacterium longum reflects its adaptation RT to the human gastrointestinal tract."; RL Proc. Natl. Acad. Sci. U.S.A. 99:14422-14427(2002). CC -!- CATALYTIC ACTIVITY: 2,3,4,5-tetrahydrodipicolinate + NAD(P)(+) = CC 2,3-dihydrodipicolinate + NAD(P)H. CC -!- PATHWAY: Amino-acid biosynthesis; L-lysine biosynthesis via DAP CC pathway; tetrahydrodipicolinate from L-aspartate: step 4/4. CC -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity). CC -!- SIMILARITY: Belongs to the dihydrodipicolinate reductase family. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; AE014295; AAN24999.1; -; Genomic_DNA. DR RefSeq; NP_696363.1; -. DR HSSP; P04036; 1DRW. DR GeneID; 1022892; -. DR GenomeReviews; AE014295_GR; BL1194. DR KEGG; blo:BL1194; -. DR NMPDR; fig|206672.1.peg.1130; -. DR HOGENOM; Q8G526; -. DR OMA; Q8G526; TCIKTAE. DR BioCyc; BLON206672:BL1194-MON; -. DR BRENDA; 1.3.1.26; 39917. DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell. DR GO; GO:0005488; F:binding; IEA:InterPro. DR GO; GO:0008839; F:dihydrodipicolinate reductase activity; IEA:HAMAP. DR GO; GO:0019877; P:diaminopimelate biosynthetic process; IEA:HAMAP. DR GO; GO:0055114; P:oxidation reduction; IEA:UniProtKB-KW. DR HAMAP; MF_00102; -; 1. DR InterPro; IPR000846; DapB. DR InterPro; IPR011770; DapB_bac/pln. DR InterPro; IPR016040; NAD(P)-bd_dom. DR Gene3D; G3DSA:3.40.50.720; NAD(P)-bd; 1. DR PANTHER; PTHR20836; DapB_bac/pln; 1. DR Pfam; PF05173; DapB_C; 1. DR Pfam; PF01113; DapB_N; 1. DR ProDom; PD004105; DapB; 1. DR TIGRFAMs; TIGR00036; dapB; 1. DR PROSITE; PS01298; DAPB; 1. PE 3: Inferred from homology; KW Amino-acid biosynthesis; Complete proteome; Cytoplasm; KW Diaminopimelate biosynthesis; Lysine biosynthesis; NADP; KW Oxidoreductase. FT CHAIN 1 251 Dihydrodipicolinate reductase. FT /FTId=PRO_0000141412. SQ SEQUENCE 251 AA; 26245 MW; A79B25A0593E467F CRC64; MIKVSVVGAK GRMGLHVVEA VNNAEDTQLA LALDAGDDLT QITTDNTDVV VEFTVPSVSL NNVLTLIGQG VDVVVGTTGW TDEKLAQVKS AIANGPKPET QKVFIAPNFA ISAVLADYFA TKAAKYFESA EVIELHHPTK VDAPSGTAIH TAHGIAEARK AAGLAPVPDA TETDGGSRGQ VVDGIHVHAV RLRGLNAHEE VLFGNAGEQL TIRADSFDRT SFMPGVLLAV RKLAGDAPAG LTIGLDHFLD L //